Molecules/BENRALIZUMAB

BENRALIZUMAB

Molecular Identity

AntibodyApprovedFirst approved 2017

Mechanism of action: Interleukin-5 receptor subunit alpha inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

BenralizumabBENRALIZUMABBIW-8405FasenraMEDI-563

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to BENRALIZUMAB

Loading drug network...